Thrombotic Events after COVID-19 Vaccination in the Over-50s: Results from a Population-Based Study in Italy

Several European countries suspended or changed recommendations for the use of Vaxzevria (AstraZeneca) for suspected adverse effects due to atypical blood-clotting. This research aims to identify a reference point towards the number of thrombotic events expected in the Italian population over 50 yea...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ileana Baldi, Danila Azzolina, Andrea Francavilla, Patrizia Bartolotta, Giulia Lorenzoni, Diego Vanuzzo, Dario Gregori
Format: article
Langue:EN
Publié: MDPI AG 2021
Sujets:
R
Accès en ligne:https://doaj.org/article/c14df2f6ff054b3c9cbd83ad24e09c6d
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!